Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Heathrow starts search for new chair - report

(Sharecast News) - Heathrow Airport's search for a successor to long-serving chair Paul Deighton has taken off, it was reported on Tuesday. The former Treasury minister and Goldman Sachs partner has served as chair since 2016.

But according to Sky News, the west London hub has now hired recruitment firm Russell Reynolds Associates to lead the search for his replacement.

Heathrow has yet to comment on the report.

Deighton's tenure was due to come to an end on 30 April. But writing in the annual report, published earlier this year, Deighton - who was made a peer in 2012 - said he had been asked to stay on for a "limited period to help ensure a smooth transition" while new directors became familiar with the business and a new chair was appointed.

He continued: "I have therefore agreed to extend my role as chair for a limited period to ensure continuity and stability on the board during this period of transition."

Heathrow is owned by a number of funds, including French private equity group Ardian, its biggest shareholder.

Ardian agreed to buy out three other shareholders in February, taking its stake up to 32.6%.

It followed a major shake-up in the airport's ownership structure in December, which also saw Saudi Arabia's sovereign wealth fund buy a stake.

Spain's Ferrovial exited the group after 17 years following the Ardian deal - thought to be worth £870m - in February.

Under chief executive Thomas Woldbye, who was appointed in 2023, Heathrow has started pushing for a major expansion, including a long-anticipated third runway.

A formal planning application is expected to be put before parliament in 2029.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.